To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. | ChamberLight
Bills · HR 5629
IN COMMITTEE· 119TH CONGRESS
House BillHR 5629Health
To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
INTRO SEP 30· LAST ACTION SEP 30
READING
1MIN
COSPONSORS
0
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8
Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
This bill matters because it intervenes in how the federal government addresses the ongoing opioid crisis. If it passes, it could mean that the methods and accessibility of certain medication-based treatments for opioid addiction remain as they are, rather than evolving under the new HHS guidelines. This could impact how quickly and easily individuals can access care for opioid use disorder.
If the bill does not pass, the full HHS rule would go into effect, potentially bringing about new standards or expanding access to these medications. Therefore, voters should care as it determines the federal approach to managing and treating opioid addiction, directly influencing public health outcomes and the policies that govern healthcare providers.
KEY PROVISIONS
2AI-extracted
PROVISION 01
The bill blocks the final rule from the Department of Health and Human Services (HHS) titled "Medications for the Treatment of Opioid Use Disorder" from taking effect.
This is the core action of the bill, preventing new federal regulations on opioid addiction treatment medications from being implemented.
PROVISION 02
It specifically clarifies that the portion of the HHS rule related to the 'accreditation of opioid treatment programs' will still have force and effect.
This provision ensures that new standards for certifying opioid treatment centers can still proceed, even if other medication-related aspects of the rule are blocked.
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED SEP 30, 2025
House BillHR 5629Health
To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
This bill matters because it intervenes in how the federal government addresses the ongoing opioid crisis. If it passes, it could mean that the methods and accessibility of certain medication-based treatments for opioid addiction remain as they are, rather than evolving under the new HHS guidelines. This could impact how quickly and easily individuals can access care for opioid use disorder.
If the bill does not pass, the full HHS rule would go into effect, potentially bringing about new standards or expanding access to these medications. Therefore, voters should care as it determines the federal approach to managing and treating opioid addiction, directly influencing public health outcomes and the policies that govern healthcare providers.
KEY PROVISIONS
AI-extracted
high
The bill blocks the final rule from the Department of Health and Human Services (HHS) titled "Medications for the Treatment of Opioid Use Disorder" from taking effect.
This is the core action of the bill, preventing new federal regulations on opioid addiction treatment medications from being implemented.
med
It specifically clarifies that the portion of the HHS rule related to the 'accreditation of opioid treatment programs' will still have force and effect.
This provision ensures that new standards for certifying opioid treatment centers can still proceed, even if other medication-related aspects of the rule are blocked.
GLOSSARY
AI-written
Final rule
A regulation issued by a federal agency that carries the force of law, often after a period of public comment.
Opioid Use Disorder
A medical condition characterized by a problematic pattern of opioid use leading to clinically significant impairment or distress, also known as opioid addiction.
Accreditation
A process by which an organization or program is evaluated by an independent body to ensure it meets certain quality standards or requirements.
Federal Register
The official daily publication for rules, proposed rules, and notices of federal agencies and organizations, as well as executive orders and other presidential documents.
Department of Health and Human Services (HHS)
A cabinet-level department of the U.S. federal government with the goal of protecting the health of all Americans and providing essential human services.
ACTION TIMELINE
2 EVENTS
SEP 30, 25
Introduced in House
INTROREFERRAL
SEP 30, 25
Referred to the House Committee on Energy and Commerce.